Related Experiment Video
Updated: Aug 18, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Insurance premium reductions. A motivating factor in long-term hypertensive treatment
JAMA
|February 10, 1984
Insights
High blood pressure increases mortality risk and life insurance costs. Successful long-term blood pressure control can lead to lower insurance premiums, incentivizing treatment adherence.
Area of Science:
- Cardiology
- Public Health
- Insurance Medicine
Background:
- Elevated blood pressure is a significant risk factor for mortality.
- Hypertension management is crucial for long-term health outcomes.
- Insurance premiums are often influenced by health status and mortality risk.
Purpose of the Study:
- To highlight the link between hypertension, mortality, and life insurance premiums.
- To emphasize the financial incentive of blood pressure control for policyholders.
- To encourage physicians to use insurance premium reduction as a motivational tool for patients.
Main Methods:
- Review of the relationship between blood pressure, mortality rates, and life insurance underwriting.
- Analysis of insurance industry practices regarding premium adjustments for controlled hypertension.
- Physician-patient communication strategies for improving therapeutic adherence.
Main Results:
- Elevated blood pressure is associated with higher mortality and increased life insurance premium costs.
- Successful and sustained blood pressure treatment can result in reduced yearly insurance premiums.
- This financial incentive can be a powerful motivator for patients to adhere to their treatment plans.
Conclusions:
- Controlling high blood pressure offers tangible financial benefits through reduced life insurance premiums.
- Physicians can leverage this information to enhance patient motivation and adherence to antihypertensive therapy.
- Integrating health outcomes with financial incentives can improve public health management of hypertension.
Abstract:
Elevated blood pressure substantially increases mortality and requires, therefore, high premium payments for life insurance coverage. Most life insurance companies are willing to reduce the cost of yearly premiums when blood pressure is successfully treated and controlled for several years. Physicians should bring these facts to their patients' attention as a motivating factor to improve adherence to therapy.
More Related Videos
Related Concept Videos
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:23Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...